Comparison of Online-Onboard Adaptive Intensity-Modulated Radiation Therapy or Volumetric-Modulated Arc Radiotherapy With Image-Guided Radiotherapy for Patients With Gynecologic Tumors in Dependence on Fractionation and the Planning Target Volume Margin

被引:14
作者
Guberina, Maja [1 ]
Garcia, Alina Santiago [1 ]
Khouya, Aymane [1 ]
Poettgen, Christoph [1 ]
Holubyev, Kostyantyn [1 ]
Ringbaek, Toke Printz [1 ]
Lachmuth, Manfred [1 ]
Alberti, Yasemin [1 ]
Hoffmann, Christian [1 ]
Hlouschek, Julian [1 ]
Gauler, Thomas [1 ]
Luebcke, Wolfgang [1 ]
Indenkaempen, Frank [1 ]
Stuschke, Martin [1 ,2 ]
Guberina, Nika [1 ]
机构
[1] Univ Duisburg Essen, Univ Hosp Essen, Dept Radiotherapy, West German Canc Ctr, Essen, Germany
[2] Partner Site Univ Hosp Essen, German Canc Consortium, Essen, Germany
关键词
CLINICAL IMPLEMENTATION; CERVICAL-CANCER; BRACHYTHERAPY; RECOMMENDATIONS; BOOST;
D O I
10.1001/jamanetworkopen.2023.4066
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Patients with newly diagnosed locally advanced cervical carcinomas or recurrences after surgery undergoing radiochemotherapy whose tumor is unsuited for a brachytherapy boost need high-dose percutaneous radiotherapy with small margins to compensate for clinical target volume deformations and set-up errors. Cone-beam computed tomography-based online adaptive radiotherapy (ART) has the potential to reduce planning target volume (PTV) margins below 5 mm for these tumors. OBJECTIVE To compare online ART technologies with image-guided radiotherapy (IGRT) for gynecologic tumors. DESIGN, SETTING, AND PARTICIPANTS This comparative effectiveness study comprised all 7 consecutive patients with gynecologic tumors who were treated with ART with artificial intelligence segmentation from January to May 2022 at theWest German Cancer Center. All adapted treatment plans were reviewed for the new scenario of organs at risk and target volume. Dose distributions of adapted and scheduled plans optimized on the initial planning computed tomography scan were compared. EXPOSURE Online ART for gynecologic tumors. MAIN OUTCOMES AND MEASURES Target dose coverage with ART compared with IGRT for PTV margins of 5 mm or less in terms of the generalized equivalent uniform dose (gEUD) without increasing the gEUD for the organs at risk (bladder and rectum). RESULTS The first 10 treatment series among 7 patients (mean [SD] age, 65.7 [16.5] years) with gynecologic tumors from a prospective observational trial performed with ART were compared with IGRT. For a clinical PTV margin of 5 mm, IGRT was associated with a median gEUD decrease in the interfractional clinical target volume of -1.5%(90% CI, -31.8% to 2.9%) for all fractions in comparison with the planned dose distribution. Online ART was associated with a decrease of -0.02%(90% CI, -3.2% to 1.5%), which was less than the decrease with IGRT (P <.001). This was not associated with an increase in the gEUD for the bladder or rectum. For a PTV margin of 0 mm, the median gEUD deviation with IGRT was -13.1% (90% CI, -47.9% to 1.6%) compared with 0.1% (90% CI, -2.3% to 6.6%) with ART (P <.001). The benefit associated with ART was larger for a PTV margin of 0mmthan of 5mm(P =.004) due to spreading of the cold spot at the clinical target volume margin from fraction to fraction with a median SD of 2.4 cm(90% CI, 1.9-3.4 cm) for all patients. CONCLUSIONS AND RELEVANCE This study suggests that ART is associated with an improvement in the percentage deviation of gEUD for the interfractional clinical target volume compared with IGRT. As the gain of ART depends on fractionation and PTV margin, a strategy is proposed here to switch from IGRT to ART, if the delivered gEUD distribution becomes unfavorable in comparison with the expected distribution during the course of treatment.
引用
收藏
页数:12
相关论文
共 20 条
  • [1] A Phase II Trial of Stereotactic Ablative Radiation Therapy as a Boost for Locally Advanced Cervical Cancer
    Albuquerque, Kevin
    Tumati, Vasu
    Lea, Jayanthi
    Ahn, Chul
    Richardson, Debra
    Miller, David
    Timmerman, Robert
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (03): : 464 - 471
  • [2] [Anonymous], Lancet Oncol, DOI [10.1016/S1470-2045(20)30753-1, DOI 10.1016/S1470-2045(20)30753-1]
  • [3] Archambault Y, 2020, Med Phys Int J, V8, P77
  • [4] Good Research Practices for Comparative Effectiveness Research: Defining, Reporting and Interpreting Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report-Part I
    Berger, Marc L.
    Mamdani, Muhammad
    Atkins, David
    Johnson, Michael L.
    [J]. VALUE IN HEALTH, 2009, 12 (08) : 1044 - 1052
  • [5] Deep Learning for Per-Fraction Automatic Segmentation of Gross Tumor Volume (GTV) and Organs at Risk (OARs) in Adaptive Radiotherapy of Cervical Cancer
    Breto, Adrian L.
    Spieler, Benjamin
    Zavala-Romero, Olmo
    Alhusseini, Mohammad
    Patel, Nirav V.
    Asher, David A.
    Xu, Isaac R.
    Baikovitz, Jacqueline B.
    Mellon, Eric A.
    Ford, John C.
    Stoyanova, Radka
    Portelance, Lorraine
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [6] Brachytherapy or external beam radiotherapy as a boost in locally advanced cervical cancer: a Gynaecology Study Group in the Italian Association of Radiation and Clinical Oncology (AIRO) review
    Campitelli, Maura
    Lazzari, Roberta
    Piccolo, Federica
    Ferrazza, Patrizia
    Marsella, Anna Rita
    Macchia, Gabriella
    Fodor, Andrei
    Santoni, Riccardo
    Tagliaferri, Luca
    Cerrotta, Annamaria
    Aristei, Cynthia
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (09) : 1278 - 1286
  • [7] Robustness and reproducibility of an artificial intelligence-assisted online segmentation and adaptive planning process for online adaptive radiation therapy
    Chapman, John W.
    Lam, Dao
    Cai, Bin
    Hugo, Geoffrey D.
    [J]. JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2022, 23 (08):
  • [8] ESTRO-ACROP recommendations on the clinical implementation of hybrid MR-linac systems in radiation oncology
    Corradini, Stefanie
    Alongi, Filippo
    Andratschke, Nicolaus
    Azria, David
    Bohoudi, Omar
    Boldrini, Luca
    Bruynzeel, Anna
    Hoerner-Rieber, Juliane
    Juergenliemk-Schulz, Ina
    Lagerwaard, Frank
    McNair, Helen
    Raaymakers, Bas
    Schytte, Tine
    Tree, Alison
    Valentini, Vincenzo
    Wilke, Lotte
    Zips, Daniel
    Belka, Claus
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 159 : 146 - 154
  • [9] Neoadjuvant Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation Versus Chemoradiation for Locally Advanced Cervical Cancer: A Randomized Phase II Trial
    da Costa, Samantha Cabral S.
    Bonadio, Renata Colombo
    Gabrielli, Flavia Carolina G.
    Aranha, Andrea S.
    Dias Genta, Maria Luiza N.
    Miranda, Vanessa C.
    de Freitas, Daniela
    Abdo Filho, Elias
    Ferreira, Patricia A. O.
    Machado, Karime K.
    Scaranti, Mariana
    Carvalho, Heloisa de A.
    Estevez-Diz, Maria Del Pilar
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (33) : 3124 - +
  • [10] Determining the recommended dose of stereotactic body radiotherapy boost in patients with cervical cancer who are unsuitable for intracavitary brachytherapy: a phase I dose-escalation study
    Ito, Kei
    Kito, Satoshi
    Nakajima, Yujiro
    Shimizuguchi, Takuya
    Ogawa, Hiroaki
    Nihei, Keiji
    Tanaka, Hiroshi
    Kino, Nao
    Yasugi, Toshiharu
    Karasawa, Katsuyuki
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (09) : 856 - 861